• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

USPSTF: Behavioral interventions do not reduce sunburn or skin cancer outcomes in adults

byAdarsh ManjunathandDaniel Fisher
March 25, 2018
in Chronic Disease, Dermatology, Oncology, Public Health
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. Behavioral interventions increase sun protection behavior but do not reduce sunburn or skin cancer outcomes in adults.

2. Behavior interventions lead to increased skin self-examinations but may lead to additional skin procedures without finding additional skin cancers.

3. The Task Force concluded that there is clear benefit to providing this counseling to people who are six months to 24 years old and have a fair skin type

Evidence Rating Level: 1 (Excellent)

Study Rundown: While melanoma comprises 2% of all skin cancers, it causes more than 80% of skin cancer deaths. UV radiation is a major environmental risk factor for all skin cancers, and behavioral counseling promoting behaviors could reduce UV exposure and thus skin cancer. This systematic review analyzed the current evidence on the benefits and harms of behavioral counseling for skin cancer prevention and found that these interventions can increase sun protection behavior. However, there is a lack of evidence that these interventions are associated with a reduction in the frequency of sunburn or improve skin cancer outcomes. While interventions may lead to more skin self-examinations, they can also lead to more skin procedures without finding skin cancers.

While the authors included numerous studies from the primary care setting, the review excluded studies taking place in worksites, schools, or other community settings, which may have an earlier or stronger impact on patients. It also excluded survivors of skin cancer, which may be a vulnerable group that would benefit most from increased education. Despite these limitations, it seems unlikely that behavioral interventions have a large impact on reducing sunburn and skin cancer risk.

Click to read the study, published in JAMA

RELATED REPORTS

#StudyGraphics: Atezolizumab in combination with vemurafenib and cobimetinib improve progression-free survival in patients with BRAFV600-advanced melanoma

#VisualAbstract: Neoadjuvant–Adjuvant vs. Adjuvant-Only Pembrolizumab in Advanced Melanoma

#VisualAbstract: Adjuvant pembrolizumab improves distant metastasis-free survival in stage IIB-C melanoma

Relevant Reading: A randomized trial to improve early detection and prevention practices among siblings of melanoma patients

In-Depth [systematic review]: This study reviewed 21 trials in 27 publications with a total of 20 561 patients in the Cochrane Central Register of Controlled Trials, MEDLINE, and PubMed regarding skin cancer prevention and skin self-examination. Several trials found intervention to have some increase in sun protection behavior in children (6 trials, n = 4252) and adults (12 trials, n = 13 099) but no consistent improvement in prevention of sunburn in children (3 trials, n = 2508) or adults (6 trials, n = 3959). A trial of skin self-examinations (n = 1356) found increased skin procedures in the intervention group vs. control group at 6 months (8.0% vs. 3.6%, p < 0.001).

Image: PD

©2018 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: skin cancersun damaged skin
Previous Post

Parental hopes for critically ill children are dynamic

Next Post

HIV incidence has decreased overall, but remains higher among minority men who have sex with men

RelatedReports

#StudyGraphics: Atezolizumab in combination with vemurafenib and cobimetinib improve progression-free survival in patients with BRAFV600-advanced melanoma
StudyGraphics

#StudyGraphics: Atezolizumab in combination with vemurafenib and cobimetinib improve progression-free survival in patients with BRAFV600-advanced melanoma

March 15, 2023
#VisualAbstract: Neoadjuvant–Adjuvant vs. Adjuvant-Only Pembrolizumab in Advanced Melanoma
StudyGraphics

#VisualAbstract: Neoadjuvant–Adjuvant vs. Adjuvant-Only Pembrolizumab in Advanced Melanoma

March 9, 2023
#VisualAbstract: Adjuvant pembrolizumab improves distant  metastasis-free survival in stage IIB-C melanoma
StudyGraphics

#VisualAbstract: Adjuvant pembrolizumab improves distant metastasis-free survival in stage IIB-C melanoma

February 13, 2023
#VisualAbstract: Pembrolizumab provides survival benefit in PD-L1 positive advanced head and neck cancer
StudyGraphics

#VisualAbstract: Nivolumab plus ipilimumab improves recurrence-free survival in patients with resected advanced melanoma

October 20, 2022
Next Post
Government-funded initiatives provide important supports to low-income HIV patients

HIV incidence has decreased overall, but remains higher among minority men who have sex with men

Radiation dose associated with increased heart disease in Hodgkin lymphoma survivors

Racial/ethnic disparities in cardiovascular health persist in U.S. adults

Microbe-rich environment associated with lower rates of asthma

No significant benefit of long-acting muscarinic antagonists over long-acting beta-agonists in reducing exacerbation risk in uncontrolled, persistent asthma

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Addition of fludrocortisone to hydrocortisone is beneficial in management of septic shock
  • Surveillance testing of staff at nursing facilities reduces resident COVID-19 mortality
  • Childhood maltreatment may cause mental health problems
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

Want more physician-written
medical news?

Join over 10 million yearly readers and numerous companies. For healthcare professionals
and the public.

Subscribe for free today!

Subscription options